Publication
Abstract
Realization of part of clinical trial called: Open clinical phase I trials with repeated increasing doses to evaluate the safety and tolerability , pharmacokinetic biological and clinical activity MSB0010718C in patients with metastatic or locally solid tumors and with the extension of the selected indication